Invest, Acquire, License, Collaborate
June 11-12, Boston MA
Accelerate collaboration and partnering across cardiovascular, renal and metabolic pipelines and technologies, to address weight maintenance, cardiorenal benefits, and pioneer first- and best-in-class therapies for underlying pathologies.
Confirmed to Attend
WHY CVRM INNOVATION PHARMA PARTNERING SUMMIT?
The Cardio-Renal-Metabolic (CVRM) Innovation Pharma Partnering Summit is a hyper-aligned business development forum for companies addressing pathologies driving cardiovascular, kidney, and metabolic diseases.
This exclusive summit brings together over 80 on-scope and in-strategy companies, providing targeted face-to-face networking, and opportunities to validate biotech innovations against the interests of pharma and qualified investors.
Designed to maximize your success, the scientifically focused environment of the summit guarantees a minimum of 25% meeting acceptance rates and at least four productive meetings with strong follow-up potential. Increase your meeting success rates and build meaningful collaborations in this exclusive setting.
"The opportunity had gone cold since the initial chats, with the other party generally hard to get hold of. Being able to use the partnering app ahead of the conference to not only find a time but have a table reserved for us to hash out a deal was super valuable and enabled us to close the partnership." Attendee ADC & Radiopharmaceuticals Pharma Partnering Summit
Key Figures from Partnering Series
meetings through the partnering portal
acceptance rate of meetings, versus 11% industry standard
total attendees, including: 20+ pharma, 60+ biotech
companies
director level and above
Size of Networking Opportunity
Total Audience Networking
Creating Alignment Through Targeted Critical Mass
Exclusive to the CVRM pharma, biotech, and investor community. Brush shoulders with C-level decision-makers guaranteeing a greater number of strategically matched interactions to foster new biotech collaborations, pharma partnerships, and investment funding. Limited attendance of CROs/CDMOs or other service providers, maximizes your opportunity to speak with the highest priority contacts for your company while they and you are free from conflicting priorities.
INTERESTED GROUP MATCHMAKING
Group Matchmaking
Tell us which pharma you want to meet in advance, and we will coordinate face-to-face, sit-down meetings with them during protected networking time at the pharma matchmaking tables on day one.
Individual Meetings: One-on-One Partnering™
The industry's favorite partnering portal, search the full attendee list, message and pre-schedule meetings in calendars ahead of the conference, and automatically book private meeting spaces: the most efficient way to set yourself up for success.
EXPERT SPEAKERS INCLUDE
Andrew Whittle
Global Head, Cardio-Renal-Metabolic BD&L
Boehringer Ingelheim
Robrecht Thoonen
Senior Director, External Innovation, Diabetes, Obesity & Cardiometabolic Diseases
Eli Lilly & Company
Philip Just Larsen
Chief Executive Officer
SixPeaks Bio
Ashley Zehnder
Founder & Chief Executive Officer
Fauna Bio
Alicia Irurzun-Lafitte
Partner
UCB Ventures
OTHER HANSON WADE SUMMITS
